Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase

Andrea Réti, Éva Pap, Vilmos Adleff, A. Jeney, Judit Kralovánszky, Barna Budai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: To prove that 5-FU cytotoxicity could be increased by combination with low-dose non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or NS-398) in high cyclooxygenase-2- (COX-2) expressing cells and xenografts through the modulation of dihydropyrimidine dehydrogenase (DPD) mRNA expression and/or enzyme activity. Methods: HT-29 cells were grown on collagen IV coated plates (HT-29-C). The antiproliferative effect of 5-fluorouracil (5-FU) ± NSAIDs was examined on non-COX-2 expressing HT-29 and COX-2-expressing HT-29-C cells by sulphorhodamine B assay. The COX-2 and DPD expressions were visualized by immunofluorescent staining, and prostaglandin E2 levels were measured by ELISA kit. The HT-29 xenograft was established in SCID mice and treated with 5-FU ± NSAIDs for 5 days. The tumor volume, enzyme activity, and DPD mRNA expression were investigated by caliper, radioenzymatic method, and realtime RT-PCR, respectively. The drug interaction was calculated for both combinations (5-FU + indomethacin and 5-FU + NS-398). Results: Collagen IV up-regulated significantly the COX- 2 and DPD mRNA, and protein expressions, and also their enzyme activities in HT-29 cells. NSAIDs enhanced in a synergistic manner the cytotoxic effect of 5-FU treatment both in vitro and in vivo. Downregulation of DPD was observed after 5-FU monotherapy, but the combined effect of NSAIDs and 5-FU on DPD mRNA expression, and enzyme activity was superior to the effect of 5-FU alone. Conclusions: Since 5-FU + NSAID treatment can alter the DPD enzyme activity resulting in an enhanced cytotoxic effect, further studies in clinical practice are warranted.

Original languageEnglish
Pages (from-to)219-227
Number of pages9
JournalCancer Chemotherapy and Pharmacology
Volume66
Issue number2
DOIs
Publication statusPublished - Jul 2010

Fingerprint

Dihydrouracil Dehydrogenase (NADP)
Cyclooxygenase 2
Cytotoxicity
Heterografts
Fluorouracil
Colorectal Neoplasms
Anti-Inflammatory Agents
Down-Regulation
Cells
Enzyme activity
Pharmaceutical Preparations
HT29 Cells
Enzymes
Messenger RNA
lissamine rhodamine B
Indomethacin
Collagen
Drug interactions
Drug therapy
SCID Mice

Keywords

  • 5-fluorouracil
  • Cyclooxygenase-2
  • Dihydropyrimidine dehydrogenase
  • Indomethacin
  • NS-398

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Toxicology

Cite this

Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase. / Réti, Andrea; Pap, Éva; Adleff, Vilmos; Jeney, A.; Kralovánszky, Judit; Budai, Barna.

In: Cancer Chemotherapy and Pharmacology, Vol. 66, No. 2, 07.2010, p. 219-227.

Research output: Contribution to journalArticle

@article{9128e2a6e97c4aaeb4b212da70d17967,
title = "Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase",
abstract = "Purpose: To prove that 5-FU cytotoxicity could be increased by combination with low-dose non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or NS-398) in high cyclooxygenase-2- (COX-2) expressing cells and xenografts through the modulation of dihydropyrimidine dehydrogenase (DPD) mRNA expression and/or enzyme activity. Methods: HT-29 cells were grown on collagen IV coated plates (HT-29-C). The antiproliferative effect of 5-fluorouracil (5-FU) ± NSAIDs was examined on non-COX-2 expressing HT-29 and COX-2-expressing HT-29-C cells by sulphorhodamine B assay. The COX-2 and DPD expressions were visualized by immunofluorescent staining, and prostaglandin E2 levels were measured by ELISA kit. The HT-29 xenograft was established in SCID mice and treated with 5-FU ± NSAIDs for 5 days. The tumor volume, enzyme activity, and DPD mRNA expression were investigated by caliper, radioenzymatic method, and realtime RT-PCR, respectively. The drug interaction was calculated for both combinations (5-FU + indomethacin and 5-FU + NS-398). Results: Collagen IV up-regulated significantly the COX- 2 and DPD mRNA, and protein expressions, and also their enzyme activities in HT-29 cells. NSAIDs enhanced in a synergistic manner the cytotoxic effect of 5-FU treatment both in vitro and in vivo. Downregulation of DPD was observed after 5-FU monotherapy, but the combined effect of NSAIDs and 5-FU on DPD mRNA expression, and enzyme activity was superior to the effect of 5-FU alone. Conclusions: Since 5-FU + NSAID treatment can alter the DPD enzyme activity resulting in an enhanced cytotoxic effect, further studies in clinical practice are warranted.",
keywords = "5-fluorouracil, Cyclooxygenase-2, Dihydropyrimidine dehydrogenase, Indomethacin, NS-398",
author = "Andrea R{\'e}ti and {\'E}va Pap and Vilmos Adleff and A. Jeney and Judit Kralov{\'a}nszky and Barna Budai",
year = "2010",
month = "7",
doi = "10.1007/s00280-009-1149-8",
language = "English",
volume = "66",
pages = "219--227",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase

AU - Réti, Andrea

AU - Pap, Éva

AU - Adleff, Vilmos

AU - Jeney, A.

AU - Kralovánszky, Judit

AU - Budai, Barna

PY - 2010/7

Y1 - 2010/7

N2 - Purpose: To prove that 5-FU cytotoxicity could be increased by combination with low-dose non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or NS-398) in high cyclooxygenase-2- (COX-2) expressing cells and xenografts through the modulation of dihydropyrimidine dehydrogenase (DPD) mRNA expression and/or enzyme activity. Methods: HT-29 cells were grown on collagen IV coated plates (HT-29-C). The antiproliferative effect of 5-fluorouracil (5-FU) ± NSAIDs was examined on non-COX-2 expressing HT-29 and COX-2-expressing HT-29-C cells by sulphorhodamine B assay. The COX-2 and DPD expressions were visualized by immunofluorescent staining, and prostaglandin E2 levels were measured by ELISA kit. The HT-29 xenograft was established in SCID mice and treated with 5-FU ± NSAIDs for 5 days. The tumor volume, enzyme activity, and DPD mRNA expression were investigated by caliper, radioenzymatic method, and realtime RT-PCR, respectively. The drug interaction was calculated for both combinations (5-FU + indomethacin and 5-FU + NS-398). Results: Collagen IV up-regulated significantly the COX- 2 and DPD mRNA, and protein expressions, and also their enzyme activities in HT-29 cells. NSAIDs enhanced in a synergistic manner the cytotoxic effect of 5-FU treatment both in vitro and in vivo. Downregulation of DPD was observed after 5-FU monotherapy, but the combined effect of NSAIDs and 5-FU on DPD mRNA expression, and enzyme activity was superior to the effect of 5-FU alone. Conclusions: Since 5-FU + NSAID treatment can alter the DPD enzyme activity resulting in an enhanced cytotoxic effect, further studies in clinical practice are warranted.

AB - Purpose: To prove that 5-FU cytotoxicity could be increased by combination with low-dose non-steroidal antiinflammatory drugs (NSAIDs) (indomethacin or NS-398) in high cyclooxygenase-2- (COX-2) expressing cells and xenografts through the modulation of dihydropyrimidine dehydrogenase (DPD) mRNA expression and/or enzyme activity. Methods: HT-29 cells were grown on collagen IV coated plates (HT-29-C). The antiproliferative effect of 5-fluorouracil (5-FU) ± NSAIDs was examined on non-COX-2 expressing HT-29 and COX-2-expressing HT-29-C cells by sulphorhodamine B assay. The COX-2 and DPD expressions were visualized by immunofluorescent staining, and prostaglandin E2 levels were measured by ELISA kit. The HT-29 xenograft was established in SCID mice and treated with 5-FU ± NSAIDs for 5 days. The tumor volume, enzyme activity, and DPD mRNA expression were investigated by caliper, radioenzymatic method, and realtime RT-PCR, respectively. The drug interaction was calculated for both combinations (5-FU + indomethacin and 5-FU + NS-398). Results: Collagen IV up-regulated significantly the COX- 2 and DPD mRNA, and protein expressions, and also their enzyme activities in HT-29 cells. NSAIDs enhanced in a synergistic manner the cytotoxic effect of 5-FU treatment both in vitro and in vivo. Downregulation of DPD was observed after 5-FU monotherapy, but the combined effect of NSAIDs and 5-FU on DPD mRNA expression, and enzyme activity was superior to the effect of 5-FU alone. Conclusions: Since 5-FU + NSAID treatment can alter the DPD enzyme activity resulting in an enhanced cytotoxic effect, further studies in clinical practice are warranted.

KW - 5-fluorouracil

KW - Cyclooxygenase-2

KW - Dihydropyrimidine dehydrogenase

KW - Indomethacin

KW - NS-398

UR - http://www.scopus.com/inward/record.url?scp=77953049722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953049722&partnerID=8YFLogxK

U2 - 10.1007/s00280-009-1149-8

DO - 10.1007/s00280-009-1149-8

M3 - Article

C2 - 19830428

AN - SCOPUS:77953049722

VL - 66

SP - 219

EP - 227

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 2

ER -